Tradestie Institutional Equity Comparison Engine
ARVN vs RCKT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ARVN Overall Edge
ARVN Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arvinas, Inc (ARVN) driven by superior Valuation, Momentum & Technical, Options & Structure while RCKT counters with relative strength in Growth & Margin. Fundamentally, ARVN trades at 17.9x Forward P/E with -10.1% operating margin (-98.8% YoY revenue) versus RCKT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against RCKT sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ARVN
ARVN 17.9x vs RCKT N/M Fwd P/E
Growth & Margin Winner
RCKT
Op Margin -10.1% vs 0.0% ยท YoY -98.8% vs +0.0%
Momentum & Technical Winner
ARVN
1Y -33.4% vs -31.1% ยท 52W Pos 5% vs 1%
Options & Structure Winner
ARVN
BREAKDOWN (25th %ile IV) vs BREAKDOWN (30th %ile IV)
ARVN
NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap
$449.9M
1M Return
-3.3%
1Y Return
-33.4%
Forward P/E
17.9x
Unified AI Score
52.9 / 100
HOLD
Tech 54.0
Fund 59.0
Flow 71.0
Mom 54.0
RCKT
NASDAQ
Rocket Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$2.19
-5.0% 1D
Market Cap
$262.4M
1M Return
+0.23%
1Y Return
-31.07%
Forward P/E
N/M
Unified AI Score
50.2 / 100
HOLD
Tech 17.0
Fund 52.0
Flow 69.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARVN -33.4%
RCKT -31.07%
Spread: +2.33 pp (RCKT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ARVN TTM Op. Margin: -10.1%
RCKT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARVN vs RCKT. Trailing 12-month operating profitability (ARVN -10.1% vs RCKT 0.0%) and valuation multiples (ARVN 17.9x vs RCKT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARVN | RCKT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $449.9M | $262.4M | Larger Scale | ARVN |
| Trailing P/E Ratio Valuation | 17.9x | N/M | Lower Multiple | ARVN |
| Forward P/E Ratio Valuation | 17.9x | N/M | Lower Multiple | ARVN |
| Revenue Growth (YoY) Growth | -98.8% | +0.0% | Higher Growth | RCKT |
| Operating Margin (TTM) Profitability | -10.1% | 0.0% | Higher Margin | RCKT |
| Net Profit Margin Profitability | -3.5% | 0.0% | Higher Margin | RCKT |
| Return on Equity (ROE) Capital Efficiency | -1.8% | -4.8% | Higher ROE | ARVN |
| 52-Week Range Position Momentum | 5% ($6โ$15) | 1% ($2โ$5) | Stronger Trend | ARVN |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 66% Vol | 1.76ฮฒ ยท 67% Vol | Lower Realized Risk | ARVN |
| Unified Institutional Score Composite Signal | 52.9 / 100 (HOLD) | 50.2 / 100 (HOLD) | Higher Composite | ARVN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARVN vs RCKT Buy Guide
ARVN
BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
RCKT
BREAKDOWN
92d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
30th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARVN nor RCKT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.